Phekolo ea kankere ea tšoelesa ea senya ea brca gene

Boteng ba a Mofuta oa BRCA Phetoho ea liphatsa tsa lefutso, eo hangata e amahanngoang le mofetše oa matsoele le oa mahe a bomme, e ka boela ea phetha karolo ea bohlokoa ntlafatsong le kalafong ea kankere ea senya. Ho utloisisa se boleloang ke liphetoho tsena ke habohlokoa bakeng sa mekhoa ea phekolo ea motho ka mong le liphello tse ntlafetseng tsa mokuli. Sengoliloeng sena se hlahloba kamano pakeng tsa Liphatsa tsa lefutso tsa BRCA le kankere ea senya, ho hlahlobisisa tlhahlobo, mekhoa ea kalafo, le lipatlisiso tse tsoelang pele.Kutloisiso ea Liphatsa tsa lefutso tsa BRCA le Karolo ea TsonaLiphatsa tsa lefutso tsa BRCA1 le BRCA2 ke life?BRCA1 le BRCA2 ke liphatsa tsa lefutso tsa motho tse hlahisang liprotheine tse ikarabellang bakeng sa ho lokisa DNA e senyehileng. Liprotheine tsena li phetha karolo ea bohlokoa ho boloka botsitso ba boitsebiso ba liphatsa tsa lefutso le ho thibela ho hōla ho sa laoleheng ha lisele. Ha liphatsa tsa lefutso tsena li fetoha, li ke ke tsa hlola li lokisa tšenyo ea DNA ka katleho, ho eketsa kotsi ea ho tšoaroa ke kankere e itseng. BRCA1 le BRCA2 hangata li amahanngoa le kotsi e eketsehileng ea kankere ea matsoele le ea mahe a bomme ho basali. Leha ho le joalo, liphetoho tsena li boetse li phahamisa kotsi ea lik'hemik'hale tse ling, ho kenyeletsa kankere ea senya, kankere ea pancreatic, le melanoma. Banna ba nang le a Mofuta oa BRCA phetoho ea liphatsa tsa lefutso e na le monyetla o moholo oa ho ba mabifi kankere ea senya a sa le monyenyane lilemong.BRCA Mutations and Prostate CancerKeketseho ea Kotsi le AggressivenessLithuto li bontšitse hore banna ba nang le BRCA1 kapa BRCA2 liphetoho tsa liphatsa tsa lefutso li na le kotsi e kholo ea ho hlaha kankere ea senya bapisoa le banna ba se nang liphetoho tsena. Ho feta moo, kankere ea senya ho banna ba nang le BRCA Liphatsa tsa lefutso li atisa ho ba mabifi, hangata li hlahisa hamorao le lintlha tse phahameng tsa Gleason. Setsi sa Naha sa Kankere e fana ka lintlha tse ling ka BRCA liphatsa tsa lefutso le kotsi ea mofetše.Screening and Genetic TestingKa lebaka la kotsi e eketsehileng, tlhahlobo ea liphatsa tsa lefutso bakeng sa BRCA1 le BRCA2 liphatsa tsa lefutso li buelloa ho banna ba nang le nalane ea lelapa la kankere ea senya, haholo-holo haeba kankere e fumanoe e sa le monyenyane kapa haeba ho na le histori ea kankere ea matsoele, ea mahe a bomme kapa ea pancreatic ka lapeng. Ho lemoha kapele ka ho hlahloba, joalo ka tlhahlobo ea PSA (prostate-specific antigen) le litlhahlobo tsa rectal tsa dijithale, le tsona ke tsa bohlokoa ho banna ba kotsing e kholo. Teko ea liphatsa tsa lefutso le eona e fumaneha litsing tse kang Setsi sa Lipatlisiso sa Kankere sa Shandong Baofa, moo ho fanoang ka litlhahlobo tsa motho ka mong tsa kotsi ea mofetše.Tlhaloso ea Kalafo ea Kankere ea tšoelesa ea tšoelesa ea senya bakeng sa Banna ba nang le BRCA MutationsTargeted Therapies: PARP InhibitorsPARP (poly ADP-ribose polymerase) inhibitors ke sehlopha sa litlhare tse bonts'itseng litholoana tse ts'episang kalafong. kankere ea senya ho banna ba nang le BRCA liphetoho liphatseng tsa lefutso. PARP inhibitors e sebetsa ka ho thibela enzyme ea PARP, e amehang ho lokisoeng ha DNA. Lisele tsa mofets'e tse nang le BRCA Liphatsa tsa lefutso li kotsing haholo ho thibelo ea PARP hobane li se li ntse li e-na le mokhoa oa ho lokisa DNA o senyehileng. Tse ling tse tloaelehileng tsa PARP inhibitors li kenyelletsa olaparib (Lynparza) le rucaparib (Rubraca). Kamoo PARP Inhibitors Sebetsang Ha BRCA Liphatsa tsa lefutso li fetoha, lisele tsa mofetše li itšetleha ka litsela tse ling tsa ho lokisa DNA, ho kenyelletsa le tsela ea PARP. Ka ho thibela enzyme ea PARP, li-inhibitors tsa PARP li thibela lisele tsa kankere ho lokisa tšenyo ea DNA, e lebisang lefung la sele. Mokhoa ona o lebisitsoeng o sebetsa ka ho khetheha ho kankere ea senya lisele tse nang le BRCA liphetoho tse fetohang, kaha ha li khone ho lokisa tšenyo ea DNA ka mokhoa o nepahetseng ka mekhoa e meng.Liteko tsa bongaka tsa bongaka li bontšitse katleho ea PARP inhibitors ho phekola maemo a tsoetseng pele. kankere ea senya ho banna ba nang le BRCA liphetoho liphatseng tsa lefutso. Mohlala, teko ea BOHLOKOA e bonts'itse hore olaparib e ntlafalitse haholo ho phela ka kakaretso le ho phela ntle le radiographic ho banna ba nang le metastatic castration-resistant. kankere ea senya (mCRPC) le BRCA1 kapa BRCA2 liphetoho liphatseng tsa lefutso. Liphetho tse tsoang tekong ea BOHLOKOA li ka fumanoa ho New England Journal of Medicine.Mekhoa e meng ea KalafoLe ha PARP inhibitors e le khetho ea phekolo e lebisitsoeng, maemo a mang kankere ea senya liphekolo li ka boela tsa sebelisoa ho banna ba nang le BRCA liphetoho liphatseng tsa lefutso. Tsena li kenyelletsa: Opereishene: Radical prostatectomy (ho tlosoa ha tšoelesa ea senya) e ka 'na ea e-ba khetho bakeng sa libaka kankere ea senya. Kalafo ea Mahlaseli: Kalafo ea radiation ea kantle kapa brachytherapy (mahlaseli a ka hare) a ka sebelisoa ho lebisa le ho senya lisele tsa mofetše. Phekolo ea Hormone: Androgen deprivation therapy (ADT) e ikemiselitse ho theola maemo a testosterone, a ka liehisang kholo ea kankere ea senya lisele. Chemotherapy: Lithethefatsi tsa chemotherapy li ka sebelisoa ho phekola maemo a tsoetseng pele kankere ea senya e se e nametse likarolong tse ling tsa 'mele.Bokamoso ba Phekolo ea Kankere ea tšoelesa e amanang le BRCA-Related Prostate Cancer Research e Tsoelang Pele le Liteko tsa MerianaPatlisiso e ntse e tsoela pele ho utloisisa haholoanyane karolo ea BRCA liphetoho tse teng kankere ea senya le ho hlahisa mekhoa e mecha ea phekolo e sebetsang haholoanyane. Liteko tsa kliniki li ntse li hlahloba tšebeliso ea li-inhibitors tsa PARP hammoho le liphekolo tse ling, hammoho le ho batlisisa lipakane tse ncha tsa lithethefatsi le mekhoa ea phekolo ea motho. BRCA liphetoho tse teng kankere ea senya bakuli ba totobatsa bohlokoa ba meriana ea motho ka mong le oncology e nepahetseng. Ka ho utloisisa liphatsa tsa lefutso tsa mofetše oa motho, lingaka li ka hlophisa maano a kalafo ho ntlafatsa katleho le ho fokotsa litlamorao. Tlhahlobo ea liphatsa tsa lefutso bakeng sa BRCA le liphatsa tsa lefutso tse ling tse amanang le mofetše li ntse li ata haholo kankere ea senya tsamaiso.Letlapa: Kakaretso ea Likhetho tsa Phekolo bakeng sa BRCA-mutated Prostate Cancer Treatment Option Tlhaloso Ho loketse bakeng sa BRCA-mutated Prostate Cancer PARP Inhibitors Lithethefatsi tse thibelang enzyme ea PARP, ho thibela ho lokisoa ha DNA liseleng tsa mofetše. E sebetsa haholo, haholo-holo maemong a tsoetseng pele. Ho Buoa Ho tlosoa ha tšoelesa ea senya. E loketse mofets'e oa lehae; katleho e sa amaneng ka kotloloho le boemo ba BRCA. Radiation Therapy Tšebeliso ea mahlaseli a matla a phahameng ho bolaea lisele tsa mofetše. E sebetsa, empa boemo ba BRCA bo ka ama karabelo. Hormone Therapy e theola maemo a testosterone ho fokotsa kholo ea mofets'e. Kalafo e tloaelehileng, katleho e sa amaneng ka kotloloho le boemo ba BRCA. Chemotherapy Tšebeliso ea lithethefatsi ho bolaea lisele tsa mofetše. E sebelisoa ka mekhahlelo e tsoetseng pele, boemo ba BRCA bo ka ama karabelo. ConclusionHo utloisisa kamano pakeng tsa Liphatsa tsa lefutso tsa BRCA le kankere ea senya e bohlokoa bakeng sa ho ntlafatsa tlhahlobo, kalafo, le liphetho ho batho ba amehileng. Teko ea liphatsa tsa lefutso, liphekolo tse lebisitsoeng joalo ka PARP inhibitors, le lipatlisiso tse tsoelang pele li bula tsela bakeng sa mekhoa ea motho ka mong le e sebetsang haholoanyane ea ho laola. kankere ea senya ho banna ba nang le BRCA liphetoho liphatseng tsa lefutso. Banna ba nang le nalane ea lelapa la kankere ea senya kapa mefetše e meng e amanang le eona e lokela ho nahana ka tlhahlobo ea liphatsa tsa lefutso le ho buisana ka mekhoa e nepahetseng ea tlhahlobo le bafani ba bona ba tlhokomelo ea bophelo. Litsebi tse inehetseng litsing tse kang Shandong Baofa Cancer Research Institute, e tsebahalang ka kalafo ea mofetše, li kenya letsoho ka mafolofolo tsoelopeleng ea tšebetso ena.